By Amanda Gardner
HealthDay Reporter
WEDNESDAY, Sept. 7 (HealthDay News) — Sean Callan, a stone mason in New York City, was working just seven blocks from the World Trade Center when he heard the explosion of the first plane hitting the North Tower on Sept. 11, 2001.
FRIDAY, Aug. 19 (HealthDay News) — Very few babies and children treated for coughs or respiratory illnesses have pertussis, a highly contagious childhood disease also known as whooping cough, Swiss researchers have found.
The findings should reassure doctors they aren’t overlooking or misdiagnosing the illness, which is known for a distinctive-sounding and uncontrollable cough.
TUESDAY, July 5 (HealthDay News) — The Arcapta Neohaler (indacaterol inhalation powder) has been approved by the U.S. Food and Drug Administration for the long-term treatment of chronic obstructive pulmonary disease (COPD).
COPD symptoms include airflow obstruction, breathlessness, chronic cough and excessive phlegm, the agency said in a news release. Cigarette smoking is a primary cause of COPD, which includes chronic bronchitis or emphysema.
By Steven Reinberg
HealthDay Reporter
WEDNESDAY, June 29 (HealthDay News) — Between 1998 and 2009 there was no significant decline in cases of the often deadly ailment known as chronic obstructive pulmonary disease (COPD), and the burden of the disease has shifted from men to women, a new report finds.
By 2009, 11.8 million Americans aged 18 and over suffered from the progressive respiratory illness — about 1 in every 20 adults, according to the report from the U.S. Centers for Disease Control and Prevention. Just over 6 percent of women now have COPD, the study found, compared to just over 4 percent of men.
TUESDAY, June 14 (HealthDay News) — A mist inhaler with the drug Spiriva is associated with a 52 percent increased risk of death among people with chronic obstructive pulmonary disease (COPD), a new review shows.
The mist inhaler with the soluble form of Spiriva (tiotropium) is approved in 55 countries, but is not yet approved in the United States. However, the powdered form of Spiriva is commonly used to treat COPD patients in the United States.
TUESDAY, June 7 (HealthDay News) — Abnormalities identified on the right side of a person’s heart could signal conditions involving both the heart and lungs, according to new research.
In conducting the first large imaging study of the heart’s right ventricle, or lower right chamber, researchers found that the size and pumping ability of the right side of a person’s heart differs, depending on their age, gender and race or ethnicity.
MONDAY, May 23 (HealthDay News) — New research suggests that a certain class of drugs used to treat chronic obstructive pulmonary disease (COPD) boosts the risk that male patients will be unable to urinate.
The disease, which makes breathing difficult due to inflammation and blockage in the body’s air passages, affects an estimated 10 percent of people aged 40 and older.
By Jenifer Goodwin
HealthDay Reporter
WEDNESDAY, April 27 (HealthDay News) — About 154 million Americans — or more than half the U.S. population — live in areas where the air is so polluted that it is often dangerous to breathe, a new report says.
Residents of Honolulu and Santa Fe-Espanola, N.M., on the other hand, are in luck: Those two cities had air that is among the country’s cleanest — and they were the only two in the nation that had no days in which smog and soot levels reached unhealthy ranges.
By Serena Gordon
HealthDay Reporter
THURSDAY, March 31 (HealthDay News) — While the risks of gunfire and explosive devices to U.S. soldiers stationed in Iraq are obvious, new research suggests that high levels of air pollution in that country might pose a threat to their respiratory health.
Scientists have been collecting air samples in Baghdad since 2008, and they found that the Iraqi air often contains fine particulate matter made up of many elements, including silica, sulfates and heavy metals, such as lead, arsenic, cadmium and mercury. Fine particulate matter is of greater concern than large particulate matter because these tiny particles can travel deep into the lungs, where they can cause more damage.
WEDNESDAY, March 16 (HealthDay News) — Newly proposed national standards for mercury, arsenic and other toxic air pollutants from power plants could prevent as many as 17,000 premature deaths and 11,000 heart attacks a year, according to the U.S. Environmental Protection Agency.
The proposed standards, released Wednesday by the EPA in response to a court deadline, could also prevent 120,000 cases of childhood asthma symptoms and 11,000 cases of acute bronchitis among children each year; avert more than 12,000 emergency room visits and hospital admissions annually; and lead to 850,000 fewer days of work missed due to health problems.
| Text Size: |  |
|
